Biogen Inc. (BIIB) was upgraded to a "buy" by TheStreet's Quant Ratings service on Wednesday. This biotech name has made a chart that could be challenging to many traders and investors. Let's drill down and see if an easier approach to the long side can be found.
More from Stocks
Instead of searching for a market top, look for opportunities and then manage them tightly as this continues to be a market for stock pickers.
Let's review the charts and indicators.
With the stock breaking out to a new high, a fresh look is in order.
Don't mistake a fear of missing out for a fundamental change in the industry.
An investor's job -- long or short -- is to take the opposite side of a position, and here's why we should take a critical look at this electric vehicle company.